Header Logo

Connection

Yuichi Sumii to Adjuvants, Pharmaceutic

Back to Details
This is a "connection" page, showing publications Yuichi Sumii has written about Adjuvants, Pharmaceutic.
Yuichi Sumii
Connection Strength
0.045
Adjuvants, Pharmaceutic
  1. Reduced dose of PTCy followed by adjuvant a-galactosylceramide enhances GVL effect without sacrificing GVHD suppression. Sci Rep. 2021 06 23; 11(1):13125.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.